IHS Chemical Week

Regions :: North America :: Canada

Mitsubishi Chemical completes acquisition of Medicago

12:05 AM MDT | September 20, 2013 | Deepti Ramesh

Mitsubishi Chemical Holdings says that its Mitsubishi Tanabe Pharma (Osaka) subsidiary has completed the previously announced acquisition of Canadian pharmaceutical company Medicago (Quebec City). Medicago will be operated as a joint venture owned 60% by Mitsubishi Tanabe Pharma and 40% by Philip Morris Investments (Bergen op Zoom, Netherlands). Medicago is a clinical-stage biopharmaceutical company that develops vaccines and therapeutic proteins to address a range of infectious diseases. Shares of Medicago were delisted from trading on the Tokyo Stock Exchange...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa